Artificial Intelligence: AI Finds Anti-Aging Compounds

Researchers at the University of Surrey tested their findings on the worm pictured above. It has a human-like metabolism.

Researchers at the University of Surrey have taken a step forward in the journey to develop pharmaceuticals that slow down human aging. They have developed an AI model that can scan chemical compounds and detect their suitability for use in anti-aging innovations. (EurekAlert!)

Surrey’s AI model

Scientists from the University developed an AI model and trained it on the information from the DrugAge database. Its mission: Predict whether a compound could prolong the lifespan of Caenorhabditis elegans (C. elegans)- a translucent worm that shares a similar metabolism to humans.

The worm (pictured) is therefore well-suited for studies related to obesity, diabetes, and aging.

Because the worm has a short lifespan, it makes an excellent subject for studying the effect of anti-aging compounds.

Another study of C. elegans at the Department of Endocrinology and Metabolism, First Affiliated Hospital of Jilin University, Changchun, China, concluded:  “As a model system, the nematode C. elegans could be used for studying genetic approaches to understand the aging process, age-related diseases, mechanisms of longevity, and drug screening for compounds that increase lifespan. Longevity studies on this lower organism have helped provide an outline of the signaling pathways involved in aging and predicting their behavior in complex organisms.”


The AI model detected three compounds that have an 80% chance of elongating the life span of C. elegans.

These were flavonoids, fatty acids, and organooxygens.

“Ageing is increasingly being recognized as a set of diseases in modern medicine, and we can apply the tools of the digital world, such as AI, to help slow down or protect against aging and age-related diseases,” said Sofia Kapsiani, co-author of the study and final year undergraduate student at the University of Surrey.

“Our study demonstrates the revolutionary ability of AI to aid the identification of compounds with anti-aging properties.”

Related Story:  FDA Grants Breakthrough Device Designation To Israeli Startup Ibex’s AI-Powered Galen Platform For Cancer Detection

Image of Caenorhabditis elegans hermaphrodite adult: Wikimedia Commons                                                 

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
Digital Assets: Russian Energy Firms Seek Go-Ahead To Use Flared Gas For Mining Crypto
October 22, 2021     Digital Assets, ESG and Sustainability, News

Russia’s crypto mining industry is in expansion mode after China’s clampdown on its crypto miners. Also wanting to join the party are Russian oil and gas companies that flare, or…
Artificial Intelligence: Rossum, The Document AI Company, Raises $100M
October 22, 2021     Artificial Intelligence, News, Venture Capital

Rossum offers an end-to-end AI document processing solution that combines its cognitive data capture platform with a full suite of integration capabilities to automate document-based communications between diverse businesses. The…
Alternative Investments/ESG: New York Life Floats ETFs For Gender Equality, Clean Oceans, Cleaner Transport

The three thematic ETFs meet investor demand for ESG approaches. IndexIQ, the New York Life Investments company, announced Wednesday the launch of three new ETFs. The IQ Engender Equality ETF…
FinTech: Wells Fargo Invests $10M In Cloud Payments Provider Volante
October 21, 2021     FinTech, News, Venture Capital

Volante Capital, a provider of cloud payment services and financial messaging, announced Wednesday an investment of $10 million by Wells Fargo Strategic Capital. Wells Fargo joins Wavecrest Growth Partners, BNY…